BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29652082)

  • 1. Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
    Claassen YHM; van Sandick JW; Hartgrink HH; Dikken JL; De Steur WO; van Grieken NCT; Boot H; Cats A; Trip AK; Jansen EPM; Meershoek-Klein Kranenbarg WM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Br J Surg; 2018 May; 105(6):728-735. PubMed ID: 29652082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial.
    Claassen YHM; de Steur WO; Hartgrink HH; Dikken JL; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Kranenbarg WMM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Ann Surg; 2018 Dec; 268(6):1008-1013. PubMed ID: 28817437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.
    Claassen YHM; Hartgrink HH; de Steur WO; Dikken JL; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Kranenbarg WMM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Gastric Cancer; 2019 Mar; 22(2):369-376. PubMed ID: 30238171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS Trial.
    Claassen YHM; van Amelsfoort RM; Hartgrink HH; Dikken JL; de Steur WO; van Sandick JW; van Grieken NCT; Cats A; Boot H; Trip AK; Jansen EPM; Kranenbarg EM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Ann Surg; 2019 Dec; 270(6):1096-1102. PubMed ID: 29995679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of a composite hospital volume on outcomes for gastric cancer surgery: A Dutch population-based study.
    Busweiler LAD; Dikken JL; Henneman D; van Berge Henegouwen MI; Ho VKY; Tollenaar RAEM; Wouters MWJM; van Sandick JW
    J Surg Oncol; 2017 May; 115(6):738-745. PubMed ID: 28505401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
    de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
    Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
    Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
    Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.
    Dikken JL; Dassen AE; Lemmens VE; Putter H; Krijnen P; van der Geest L; Bosscha K; Verheij M; van de Velde CJ; Wouters MW
    Eur J Cancer; 2012 May; 48(7):1004-13. PubMed ID: 22456179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
    Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
    JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Claassen YHM; Hartgrink HH; Dikken JL; de Steur WO; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Meershoek-Klein Kranenbarg WM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Eur J Surg Oncol; 2018 May; 44(5):613-619. PubMed ID: 29503129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
    Enzinger PC; Benedetti JK; Meyerhardt JA; McCoy S; Hundahl SA; Macdonald JS; Fuchs CS
    Ann Surg; 2007 Mar; 245(3):426-34. PubMed ID: 17435550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    van Putten M; Nelen SD; Lemmens VEPP; Stoot JHMB; Hartgrink HH; Gisbertz SS; Spillenaar Bilgen EJ; Heisterkamp J; Verhoeven RHA; Nieuwenhuijzen GAP
    Br J Surg; 2018 Dec; 105(13):1807-1815. PubMed ID: 30132789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do hospital attributes predict guideline-recommended gastric cancer care in the United States?
    Dudeja V; Gay G; Habermann EB; Tuttle TM; Tseng JF; Feig BW; Al-Refaie WB
    Ann Surg Oncol; 2012 Feb; 19(2):365-72. PubMed ID: 21837530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes - A Dutch population-based cohort study.
    Visser E; Brenkman HJF; Verhoeven RHA; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2017 Oct; 43(10):1862-1868. PubMed ID: 28844574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical gastrectomy for gastric cancer at Tata Memorial Hospital.
    Bhandare MS; Kumar NAN; Batra S; Chaudhari V; Shrikhande SV
    Indian J Cancer; 2017; 54(4):605-608. PubMed ID: 30082543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Outcomes of Minimally Invasive Gastrectomy Versus Open Gastrectomy During the Early Introduction of Minimally Invasive Gastrectomy in the Netherlands: A Population-based Cohort Study.
    Brenkman HJF; Gisbertz SS; Slaman AE; Goense L; Ruurda JP; van Berge Henegouwen MI; van Hillegersberg R;
    Ann Surg; 2017 Nov; 266(5):831-838. PubMed ID: 28742708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Outlier Hospitals in Gastric Cancer Lymph Node Yield Using the National Cancer Database.
    Giambra OM; Young KA; Buonpane CL; Dove JT; Shabahang MM; Blansfield J
    J Surg Res; 2021 May; 261():196-204. PubMed ID: 33450628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.